AKT1 and breast carcinoma: Another lncRNA, MIR497HG, is suppressed by ZEB1-mediated recruitment of DNMT3B and HDAC1/2 in endocrine-resistant breast cancer; meanwhile, ERα enhances its expression in sensitive conditions, affecting the PI3K/Akt pathway via miR-195/497[73].